| Why carry out this study? |
| The STELLA-LONG TERM observational study investigated the safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes during 3 years of real-world use. |
| This prespecified subgroup analysis investigated outcomes in STELLA-LONG TERM among patients aged < 65 years and ≥ 65 years, since elderly people represent a high proportion of the Japanese population. |
| What was learned from this study? |
| Long-term ipragliflozin therapy was well tolerated and effective in all elderly patients, including those in the 75 years and older age group and those with a baseline body mass index < 25 kg/m2. |
| No new safety concerns were identified, but the incidence of serious adverse drug reactions was significantly higher in elderly than non-elderly patients. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.